Over two days, 70 early-career ADA Scholars convened for a unique opportunity to engage with peers and senior leaders while participating in programming designed to support their career growth at a pivotal stage.
The dynamic four-day program developed by this year’s Scientific Sessions Planning Committee is packed with scientific discovery, clinical innovation, networking channels, and more for researchers and healthcare professionals dedicated to advancing the prevention, treatment, care, and the long-sought cure for diabetes.
Presentations in this opening-day symposium will include a review of recent literature on the clinical application of glucagon-like peptide-1 (GLP-1)-based drugs by Julio E. Ayala, PhD, who will also identify knowledge gaps that can guide future clinical trials.
Prabhleen (Sheena) Singh, MD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 4:30 p.m. CT.
Sonali Thosani, MD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Monday, June 8, at 1:30 p.m. CT.
Carlos E. Mendez, MD, FACP, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Monday, June 8, at 3:15 p.m. CT.
Charlotte Chen, DO, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Monday, June 8, at 8:00 a.m. CT.
Nicole Sheanon, MD, MS, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Monday, June 8, at 8:00 a.m. CT.